News

News Room

News
Good News | Neuboron Receives Another National Key Project Approval

2024.01.15

2250
News
China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

2024.01.09

3248
News
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

2023.12.13

5504
News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15

7852
News
Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

2023.08.14

7323
News
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

2023.05.09

8201
News
China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

2023.01.31

8992
News
In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

2022.08.30

8420
News
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

2022.03.25

8519
News
Happy 2022 and everything goes well

2021.12.31

7972
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

2021.11.10

10204
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01

9637
News
The Xiamen BNCT Center and Neuboron BNCT Group

2021.09.07

9183
News
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19

8912
News
China’s First BNCT Center Makes Debut

2021.02.09

7071

Events

News Room

Good News | Neuboron Receives Another National Key Project Approval

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

Happy 2022 and everything goes well

Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

The Xiamen BNCT Center and Neuboron BNCT Group

Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

China’s First BNCT Center Makes Debut